Adam R Winstock

Summary

Affiliation: King's College London
Country: UK

Publications

  1. doi request reprint The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products
    Adam R Winstock
    King s College London, London, UK
    Hum Psychopharmacol 28:390-3. 2013
  2. doi request reprint Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample
    Adam R Winstock
    South London and Maudsley NHS Trust Kings College London, United Kingdom Global Drug Survey, London, United Kingdom
    Drug Alcohol Depend 131:106-11. 2013
  3. doi request reprint Mephedrone: use, subjective effects and health risks
    Adam Winstock
    Addictions Department, Institute of Psychiatry, King s College London and South London and Maudsley NHS Foundation Trust, and St George s Hospital Medical School, London, UK
    Addiction 106:1991-6. 2011
  4. doi request reprint "Should I stay or should I go?" Coming off methadone and buprenorphine treatment
    Adam R Winstock
    National Addiction Centre, Institute of Psychiatry, King s College London, 4 Windsor Walk, London, UK
    Int J Drug Policy 22:77-81. 2011
  5. doi request reprint Mephedrone, new kid for the chop?
    Adam R Winstock
    King s College London, Department of Addictions, Institute of Psychiatry, London, UK
    Addiction 106:154-61. 2011
  6. doi request reprint What is diversion of supervised buprenorphine and how common is it?
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, New South Wales, Australia
    J Addict Dis 28:269-78. 2009
  7. doi request reprint Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Sydney, NSW, Australia
    Addiction 105:335-42. 2010
  8. doi request reprint Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia
    Adam R Winstock
    National Addiction Centre, Kings College, London, UK
    Subst Use Misuse 45:240-52. 2010
  9. doi request reprint Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Sydney, Australia
    Drug Alcohol Rev 27:393-7. 2008
  10. doi request reprint Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia
    Adam R Winstock
    Sydney South West Area Health Service, Drug Health Services, Locked Bag 4002, Ashfield, NSW 2131, Australia
    Int J Drug Policy 19:450-8. 2008

Collaborators

Detail Information

Publications23

  1. doi request reprint The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products
    Adam R Winstock
    King s College London, London, UK
    Hum Psychopharmacol 28:390-3. 2013
    ..Concerns about the consequences of their use have been prompted by increasing reports of emergency department presentations...
  2. doi request reprint Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample
    Adam R Winstock
    South London and Maudsley NHS Trust Kings College London, United Kingdom Global Drug Survey, London, United Kingdom
    Drug Alcohol Depend 131:106-11. 2013
    ..The last decade has seen the appearance of myriad novel psychoactive substances with diverse effect profiles. Synthetic cannabinoids are among the most recently identified but least researched of these substances...
  3. doi request reprint Mephedrone: use, subjective effects and health risks
    Adam Winstock
    Addictions Department, Institute of Psychiatry, King s College London and South London and Maudsley NHS Foundation Trust, and St George s Hospital Medical School, London, UK
    Addiction 106:1991-6. 2011
    ..To assess the patterns of use, subjective effect profile and dependence liability of mephedrone, supported by corroborative urine toxicology...
  4. doi request reprint "Should I stay or should I go?" Coming off methadone and buprenorphine treatment
    Adam R Winstock
    National Addiction Centre, Institute of Psychiatry, King s College London, 4 Windsor Walk, London, UK
    Int J Drug Policy 22:77-81. 2011
    ..The study explored previous experiences, current interest and concerns about stopping treatment, and perceptions of how and when coming off treatment should be supported...
  5. doi request reprint Mephedrone, new kid for the chop?
    Adam R Winstock
    King s College London, Department of Addictions, Institute of Psychiatry, London, UK
    Addiction 106:154-61. 2011
    ..It has a short history of human consumption and little is known about its prevalence and pattern of use. This study aimed to obtain preliminary data on its use and effects among dance drug users in the United Kingdom...
  6. doi request reprint What is diversion of supervised buprenorphine and how common is it?
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, New South Wales, Australia
    J Addict Dis 28:269-78. 2009
    ..69), and having more buprenorphine clients (odds ratio = 1.24). Future research investigating the prevalence of buprenorphine diversion should include a clear definition of what behaviors constitute diversion...
  7. doi request reprint Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Sydney, NSW, Australia
    Addiction 105:335-42. 2010
    ..To explore service provision and the range of problems that New South Wales (NSW) and Victoria (VIC) community pharmacists providing opioid substitution treatment (OST) have experienced with clients and prescribers...
  8. doi request reprint Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia
    Adam R Winstock
    National Addiction Centre, Kings College, London, UK
    Subst Use Misuse 45:240-52. 2010
    ..Further research is required to determine the optimal approach for the supervised administration of buprenorphine that maximizes the benefits of treatment and minimizes harm and the risk of diversion. The study's limitations are noted...
  9. doi request reprint Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Sydney, Australia
    Drug Alcohol Rev 27:393-7. 2008
    ..Clients in opioid substitution therapy often have considerable unmet health-care needs. The current study aimed to explore health problems related to opioid substitution therapy among clients on methadone and buprenorphine treatment...
  10. doi request reprint Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia
    Adam R Winstock
    Sydney South West Area Health Service, Drug Health Services, Locked Bag 4002, Ashfield, NSW 2131, Australia
    Int J Drug Policy 19:450-8. 2008
    ..This study aimed to investigate the prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid pharmacotherapy treatment at community pharmacies in New South Wales (NSW), Australia...
  11. ncbi request reprint High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine
    Craig P Motbey
    School of Psychology, University of Sydney, Sydney, Australia
    J Psychopharmacol 27:823-36. 2013
    ..In summary, MMC supported high levels of self-administration, matching or exceeding those previously reported with other drugs of abuse. ..
  12. doi request reprint Opioid dependent patients' experiences of and attitudes towards having their injecting sites examined
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Australia
    Int J Drug Policy 20:85-9. 2009
    ....
  13. ncbi request reprint Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation
    Louisa Degenhardt
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
    Med J Aust 191:161-5. 2009
    ..Comparison was made with injecting of two other opioid substitution treatment medications, methadone and buprenorphine (BPN); severe harms have been documented after injection of the latter...
  14. doi request reprint Methods and motivations for buprenorphine diversion from public opioid substitution treatment clinics
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, New South Wales, Australia adam
    J Addict Dis 28:57-63. 2009
    ..Responses to suspected diversion should aim to minimise harm and maximise treatment outcomes...
  15. doi request reprint Evaluation of a training program to improve clinicians' assessment of patient stability
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Sydney, Australia
    Drug Alcohol Rev 28:353-9. 2009
    ..A two-hour clinical training program was delivered to staff at 31 public clinics, that aimed to improve staff confidence in assessing client stability, and skills in negotiating the transfer of clients to community pharmacies...
  16. ncbi request reprint Safe storage of methadone takeaway doses - a survey of patient practice
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Ashfield, New South Wales, Australia
    Aust N Z J Public Health 31:526-8. 2007
    ..To determine current methadone takeaway storage practice among patients receiving supervised methadone treatment and takeaway doses at community pharmacies...
  17. doi request reprint The prevalence and natural history of urinary symptoms among recreational ketamine users
    Adam R Winstock
    Addiction CAG, South London and Maudsley NHS Foundation Trust St George s Hospital Medical School, London, UK
    BJU Int 110:1762-6. 2012
    ..It shows that symptoms may improve once ketamine use is decreased...
  18. ncbi request reprint National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Sydney, NSW
    Med J Aust 184:560-2. 2006
    ..To identify the prevalence of blood-borne viruses (BBVs) testing, counselling and vaccination services by drug and alcohol services for injecting drug users in Australia...
  19. ncbi request reprint The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Australia
    Drug Alcohol Rev 26:411-6. 2007
    ....
  20. ncbi request reprint Factors influencing pharmacy services in opioid substitution treatment
    Betty B Chaar
    Faculty of Pharmacy, The University of Sydney, Sydney, New South Wales, Australia
    Drug Alcohol Rev 32:426-34. 2013
    ..This study aimed to further investigate factors influencing pharmacists' participation in provision of OST in the community pharmacy setting in New South Wales, Australia...
  21. ncbi request reprint 4-MTA: a new synthetic drug on the dance scene
    Adam R Winstock
    National Addiction Centre, Institute of Psychiatry, Addiction Sciences Building, 4 Windsor Walk, SE5 8AF, London, UK
    Drug Alcohol Depend 67:111-5. 2002
    ..Responses to the effects of the drug were mixed, although about a quarter of those who believed that they had tried 4-MTA thought that they would use it again...
  22. pmc Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion
    Craig P Motbey
    School of Psychology, University of Sydney, New South Wales, Australia
    PLoS ONE 7:e45473. 2012
    ..Overall these results show that MMC causes acute but not lasting changes in DA and 5-HT tissue concentrations. MMC can also cause long-term memory impairment. Future studies of cognitive function in MMC users are clearly warranted...
  23. ncbi request reprint Ketamine : from medicine to misuse
    Kim Wolff
    King s College London National Addiction Centre, Institute of Psychiatry, London, England
    CNS Drugs 20:199-218. 2006
    ..The potential of ketamine as a novel clinical and research tool is matched by its abuse potential outside medical settings...